NEW YORK, Nov. 5, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Metropolitan Health Networks, Inc. ("Metropolitan" or the "Company") (NYSE: MDF) concerning the proposed acquisition of the Company by Humana Inc. ("Humana") in a transaction valued at approximately $850 million.
On November 5, 2012, it was announced that under the terms of the transaction, Metropolitan shareholders will receive $11.25 per share in cash. The price represents only a 3.7 percent premium over Metropolitan's closing price on November 2, 2012. In particular, at least one analyst set a price target for Metropolitan stock at $13.00 per share.
Our investigation concerns whether the Metropolitan board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company shareholders.
If you own Metropolitan shares and wish to discuss this matter with us, or have any questions concerning your rights and interests, please contact:
Robert I. Harwood, Esq.
Matthew H. Houston, Esq.
Christopher J. Safrath
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
Attorney Advertising© 2012 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP